Delivery Order SPE2DB20D2002-SPE2DB25FL37H

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,136.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used for the treatment of diabetes. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $2,874.44, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. This contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of...
The U.S. government awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $8,657.83. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of November 30, 2023. This contract is a firm fixed-price delivery order that is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,420.50 firm fixed-price delivery order contract is for the supply of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of August 30, 2022 and was awarded on August 29, 2022. This delivery order is part of a larger $999,999,999...
This federal contract award, valued at $1,928.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used in the management of diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of March 24, 2025. It is not designated as a set-aside contract....
This federal contract award, valued at $5,600.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 31, 2025. This award is associated with Amerisourcebergen's larger...
This federal contract award, valued at $7,364.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 31, 2025. Amerisourcebergen maintains a significant Indefinite...
This federal contract award, valued at $1,325.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg Tablets, a medication used to treat type 2 diabetes. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,552.65 firm fixed-price contract is for the supply of JANUMET 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Janumet 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,220.81 and a period of performance through August 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB25FL37H
    Delivery Order

This federal contract award, valued at $1,848.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Janumet 50-1,000 mg tablets, a medication used to treat type 2 diabetes.

The contract is a delivery order, with a firm fixed price and an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/23/25, 9:50 AM